Europe Human Milk Fortifier Market Forecast to 2030 - Regional Analysis - by Form and Distribution Channel

The Europe human milk fortifier market is expected to grow from US$ 82.62 million in 2023 to US$ 150.86 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2023 to 2030.

Increase in Number of Preterm Births Fueling the Europe Human Milk Fortifier Market

In recent years, the number of preterm births has increased owing to changing lifestyles and chronic diseases such as diabetes and high blood pressure. According to United Nations agencies and partners, a projected 13.4 million babies were delivered preterm in 2020, with almost 1 million dying from problems related to preterm birth. This translates to roughly one in ten infants delivered prematurely (before 37 weeks of pregnancy) globally. Preterm babies may have breathing problems, feeding difficulties, development delays, and vision and hearing problems.

The increasing number of preterm births has surged the demand for human milk fortifiers for the proper growth and development of infants. Many preterm infants need extra nutrients added to their mother’s milk. They often need extra protein, calcium, phosphorous, and even salt to build strong bones and healthy organs. Human milk fortifiers help provide these extra nutrients to infants. In human milk fortifiers, additional nutrients are added to the milk before it is fed to the babies.

Thus, a surge in the number of preterm births is bolstering the Europe human milk fortifier market growth.

Europe Human Milk Fortifier Market Overview

Like other regions, Europe has also witnessed a rise in premature birth rates. The trend of women delaying childbirth and getting pregnant at an older age is observed in many European countries. This factor leads to a higher risk of preterm birth. Also, certain lifestyle factors, such as smoking, alcohol consumption, drug use, and inadequate prenatal care, can contribute to an increased risk of preterm birth. All these factors cause increasing preterm births, which in turn, is boosting the demand for human milk fortifiers in the region.

Europe Human Milk Fortifier Market Revenue and Forecast to 2030 (US$ Million)

Europe Human Milk Fortifier Market Segmentation

The Europe human milk fortifier market is segmented based on form, distribution channel, and country. Based on form, the Europe human milk fortifier market is bifurcated into powder and liquid. The powder segment held a larger market share in 2023.

Based on distribution channel, the Europe human milk fortifier market is bifurcated into online and offline. The offline segment held a larger market share in 2023.

Based on country, the Europe human milk fortifier market is segmented into Germany, Italy, France, the UK, Russia, and the Rest of Europe. The Rest of Europe dominated the Europe human milk fortifier market share in 2023.

Abbott Laboratories, Nestle SA, Prolacta Bioscience Inc, Raptakos, Brett & Co Ltd, NeoKare Nutrition Ltd, Danone SA, Neolac Inc, and Reckitt Benckiser Group Plc are some of the leading companies operating in the Europe human milk fortifier market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe human milk fortifier market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe human milk fortifier market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe human milk fortifier market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution